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Target Organ Toxicity: Nervous System
by C. L. Mitchell*
This conference was organized in response to the
resurgence of interest in the behavioral and
neurological effects resulting from low-level expo-
sures to a wide variety of chemical and physical
agents. One factor in this renewed interest was the
passage of the Toxic Substance Control Act. This
law specifically states, among other things, that
chemicals should be evaluated for their behavioral
effects.
Unfortunately, real or potential risks to the ner-
vous system are difficult to assess because of the
complexity of the system. Some ofthe problems in
assessment are associated with the wide variation in
function which can occur and still lie within the
classification of "normal." Some are associated
with the plasticity of the nervous system. Other
problems in assessment are related to our incom-
plete understanding ofprecisely what is being mea-
sured by certain tests. Clearly, no single test will
suffice to examine the functional capacity of the
nervous system. During the course of this confer-
ence, it became equally clear that the current state
of our knowledge does not even warrant the selec-
tion ofabattery oftests from the myriad procedures
available. Dr. Dews stated, in his paper, that "no
methods of predicting when prolonged exposure to
a low level of an agent will lead to subtle and de-
layed behavioral effects in man have been vali-
dated." Elsewhere in this volume, Drs. Tilson and
Cabe present one approach toward the validation of
such methods.
Many behavioral toxicologists apparently either
presume or hope that behavioral tests will prove to
be more sensitive than other tests in detecting cen-
tral nervous system toxicity. Dr. Norton reminded
us, however, that "while the logical argument is
easy to propose, critical experiments are rare in
which careful behavioral studies have been paired
with detailed morphological examination." To me,
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a more convincing argument for the use of be-
havioral tests, rather than sensitivity, is that given
by Dr. Mello (1). She stated, ""the behavior of the
organism is the endpoint of the functional integra-
tion of the nervous system encompassing sensory,
motor, and cognitive aspects. The functional
capacity of the central nervous system cannot be
determined by histological or even physiological
studies independent of behavioral analysis." This
theme was also espoused by Dr. Reiter in his intro-
ductory statements to this conference. Dr. Norton
pointed out, however, that "it is the functioning of
the central nervous system that is monitored by be-
havior, not damage for which compensation occurs
or damage which affects only excess capacity or
structural redundancy." It is thus clear that mor-
phological, neurochemical, and neurophysiological
techniques are likewise important if one is to fully
examine the nervous system for toxic effects.
In the sessions on behavioral toxicology, Dr.
Reiter pointed out the need for testing procedures
which are not only sensitive indicators of toxicity
but which are also simple, rapid, and inexpensive to
perform. Dr. Laties discussed the ways in which
operant conditioning can contribute to the de-
velopment of behavioral toxicology. These were
exemplified by the papers of Dews, Stebbins and
Rudy, Evans, Annau, Wood, and Thompson and
Moerschbaecher.
With respect to neurotoxicity, Dr. LeQuesne dis-
cussed the usefulness and limitations of elec-
tromyography in detecting the toxic effects of ac-
rylamide, lead, organophosphates, hexacarbons,
and methylmercury. Drs. Spencer and Schaumburg
pointed out that there is no good systematic classifi-
cation of neurotoxins because there is a paucity of
information concerning the nature of their toxic ef-
fects. They also reminded us of the remarkable
similarity between the pathological and clinical ex-
pression ofcertain distal axonopathies and naturally
occurring neuropathies associated with diabetes,
uremia, vitamin deficiencies, old age, and certain
genetic-metabolic diseases. They pointed out that
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to neurotoxins might render a person more suscep-
tible to or accelerate the onset ofa naturally occur-
ring peripheral neuropathy. Dr. Jacobs discussed
the intriguing possibility that differences in vascular
permeability inthe nervous system might play arole
in determining the selectivity of neurotoxins
(methylmercury, for example) to particular parts of
the nervous system. Dr. Krigman emphasized the
importance of a quantitative approach to studying
the morphological effects of toxins.
It was pointed out by Dr. Damstra that our
knowledge of the primary biochemical events as-
sociated with neurotoxicity is very limited. She did,
however, present an example of how knowledge of
basic neurochemical events might contribute to the
detection of neurotoxicity. This example had to do
with the delayed neurotoxicity seen with some or-
ganophosphates. These organophosphates inhibit a
nerve cell protein called neurotoxic esterase. She
suggested it might be feasible to develop in vitro
tests for determining whether a compound has this
delayed neuropathy inducing property. Dr. Nelson
discussed the feasibility of using neuronal cell cul-
tures to assess an agent's effect on a variety of im-
portant neurobiologic parameters. Dr. Hanin gave a
review of central neurotransmitter function and
suggested that some environmental toxicants may
exert their effects by altering central neuro-
transmitter function. Dr. Dunn presented a review
of the neurochemistry oflearning and memory and
concluded with some suggestions as to neurochemi-
cal parameters to use in screening for neurochemi-
cal effects of toxicants.
The subject of variability and its consequencies
on sample size and the ability to detect a statisti-
cally significant effect ofacompound was discussed
by Dr. Dews. This is a subject which, in my opin-
ion, is too often ignored and stems in part, from a
lack of understanding of the Type II error concept
of statistics. I have dwelled on this at length
elsewhere (2). A Type II error is made whenthe null
hypothesis is accepted and it is, in fact, false. The
probability of making such an error is called ,3. We
seldom, if ever, know the value of/8. We can say
something about its relative magnitude, however.
Its value depends upon: the distance between the
population parameters being estimated by the sam-
ples (population means in the case of Student's t);
the value selected for a (the probability ofmaking a
Type I error or rejecting the null hypothesis when it
is, in fact, true); and the sample size. The smaller
the distance between the population parameters,
the larger will be [8. /8 varies inversely with a. (3
decreases as sample size increases. Thus, if you
want to detect a rather small effect and your ex-
perimental material is highly variable, you need a
large sample size. In selecting the sample size, then,
one must take these factors into consideration. You
cannot escape answering the question of"how big a
difference do I want to detect" (or "at what inci-
dence of occurrence does that effect become a fac-
tor about which something should be done")? You
either answer ifdirectly or you answer it indirectly
when you select your sample size. This is so be-
cause the smaller the sample size, the larger the
change has to be in order to be statistically signifi-
cant. There are techniques available which can tell
you the sample size needed to detect either a given
incidence of occurrence or a given change in mag-
nitude if you have an estimate of the variability in
the population(s). I cannot urge too strongly their
use. Too many studies have been conducted with
sample sizes so small that there has been no chance
to detect any real but subtle effect.
Finally, I would urge that greater consideration
be given to the reason(s) for conducting experi-
ments in behavioral and neurological toxicity. In
any emerging field, there is a certain amount of in-
formation which must be collected before concise
hypotheses can be formulated. This does not, how-
ever, excuse the investigation from critically asking
the questions of "what," "why," and "how." The
lack of a solid data base is no excuse for ill con-
ceived experiments. Indeed, the absence of infor-
mation especially calls for critical thinking. Ill con-
ceived experiments only create confusion and in-
crease the amount of information which must be
collected before intelligent decisions can be made.
Science advances most rapidly when concise,
meaningful hypotheses are tested. We need to be on
guard, then, not simply to collect information but to
continually sharpen our reasons for what we are
doing.
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